Camber Pharma Launches Generic Baraclude®
Piscataway, NJ, August 21, 2015– Camber Pharmaceuticals announces that it has launched Entecavir Tablets. The drug is the generic version of Baraclude®, which is used to treat chronic Hepatitis B.
Entecavir is available from Camber in .5mg 30 and 90 count bottles and 1mg 30 count bottles.
If you would like more information about this topic, please contact Megan Becker at 732.529.0436 or email at [email protected].
Recent articles
- Camber Launches Eslicarbazepine Acetate Tablets
- Camber Launches Phenylephrine Hydrochloride Injection, USP
- Camber Launches Chlorzoxazone Tablets, USP
- Camber Launches 13 New Generic Products in Q1 2025, Sets Ambitious Pace for the Year
- Camber Launches Lurasidone Hydrochloride Tablets
- Camber Launches Mycophenolate Mofetil Capsules